Kyverna Therapeutics
KYTX
#8309
Rank
A$0.47 B
Marketcap
A$7.61
Share price
1.35%
Change (1 day)
-22.53%
Change (1 year)

Kyverna Therapeutics (KYTX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$78.84 Million

According to Kyverna Therapeutics's latest financial reports the company's total liabilities are A$78.84 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Kyverna Therapeutics - Total liabilities on balance sheet (from 2022 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$0.20 B13.96%
2021-12-31A$0.18 B